TRxADE HEALTH Short Interest Ratio and Short Volume

+0.12 (+2.74 %)
(As of 06/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume166,925 shs
Average Volume1.84 million shs
Market Capitalization$36.42 million
P/E RatioN/A
Dividend YieldN/A


Current Short Volume3,800 shares
Previous Short Volume3,200 shares
Change Vs. Previous Month+18.75%
Dollar Volume Sold Short$13,756.00
Short Interest Ratio / Days to Cover0.0
Last Record DateMay, 28 2021
Outstanding Shares8,093,000 shares
Float Size3,140,000 shares
Short Percent of Float0.12%
Today's Trading Volume166,925 shares
Average Trading Volume1,839,588 shares
Today's Volume Vs. Average-90.93%

Short Interest Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TRxADE HEALTH ?

Sign up to receive the latest short interest report for TRxADE HEALTH and its competitors with MarketBeat's FREE newsletter.

TRxADE HEALTH (NASDAQ:MEDS) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/28/20213,800 shares $13,756.00 +18.8%0.1%0 $3.62
5/14/20213,200 shares $9,952.00 -59.0%0.1%0 $3.11
4/30/20217,800 shares $32,760.00 -70.2%0.3%0.1 $4.20
4/15/202126,200 shares $127,070.00 -28.0%0.9%0.3 $4.85
3/31/202136,400 shares $189,644.00 +561.8%1.2%0.4 $5.21
3/15/20215,500 shares $35,365.00 -3.5%0.2%0.1 $6.43
2/26/20215,700 shares $35,796.00 -78.1%0.2%0.1 $6.28
2/12/202126,000 shares $190,060.00 +38.3%0.8%0.2 $7.31
1/29/202118,800 shares $107,160.00 -77.9%0.6%0 $5.70
1/15/202185,000 shares $508,300.00 No Change2.7%0.1 $5.98


speech bubbles
speech bubbles

What is TRxADE HEALTH's current short interest?

Short interest is the volume of TRxADE HEALTH shares that have been sold short but have not yet been closed out or covered. As of May 28th, investors have sold 3,800 shares of MEDS short. 0.12% of TRxADE HEALTH's shares are currently sold short. View details.

What is a good short interest percentage for TRxADE HEALTH?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of TRxADE HEALTH's floating shares are currently sold short.

Is TRxADE HEALTH's short interest increasing or decreasing?

TRxADE HEALTH saw a increase in short interest during the month of May. As of May 28th, there was short interest totaling 3,800 shares, an increase of 18.8% from the previous total of 3,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TRxADE HEALTH's float size?

TRxADE HEALTH currently has issued a total of 8,093,000 shares. Some of TRxADE HEALTH's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TRxADE HEALTH currently has a public float of 3,140,000 shares.

How does TRxADE HEALTH's short interest compare to its competitors?

0.12% of TRxADE HEALTH's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TRxADE HEALTH: The Green Organic Dutchman Holdings Ltd. (0.00%), Ayala Pharmaceuticals, Inc. (4.32%), scPharmaceuticals Inc. (2.07%), Aytu Biopharma, Inc. (11.45%), Therapeutics Acquisition Corp. (2.99%), Eton Pharmaceuticals, Inc. (7.33%), Xtant Medical Holdings, Inc. (0.00%), Nymox Pharmaceutical Co. (11.70%), Eyenovia, Inc. (1.48%), and Liquidia Co. (5.23%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($25.04 billion), AstraZeneca PLC ($7.50 billion), Aon plc ($7.09 billion), Square, Inc. ($6.95 billion), Analog Devices, Inc. ($6.90 billion), Advanced Micro Devices, Inc. ($6.79 billion), Charter Communications, Inc. ($6.18 billion), S&P Global Inc. ($5.54 billion), Sea Limited ($4.96 billion), and Wayfair Inc. ($4.25 billion). View all of the most shorted stocks.

What does it mean to sell short TRxADE HEALTH stock?

Short selling MEDS is an investing strategy that aims to generate trading profit from TRxADE HEALTH as its price is falling. TRxADE HEALTH's stock is trading up $0.12 today. To short TRxADE HEALTH stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that TRxADE HEALTH will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TRxADE HEALTH?

A short squeeze for TRxADE HEALTH occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDS, which in turn drives the price of the stock up even further.

How often is TRxADE HEALTH's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDS, twice per month. The most recent reporting period available is May, 28 2021.

This page was last updated on 6/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.